Promise Bio
PromiseBio is a precision medicine company specializing in autoimmune diseases through epiproteomic analysis. It uses a cloud-based AI platform to perform broad-range, unbiased analyses of standard mass-spectrometry data, revealing biologically relevant insights into protein post-translational modifications that regulate disease mechanisms. The company leverages explainable AI and clinically-oriented algorithms to provide scalable, accurate predictions for treatment selection, early response assessment, disease monitoring, biomarker discovery, patient selection, and clinical trial enrichment. PromiseBio's approach enables revisiting existing data with evolving AI models without chemical enrichment, offering a comprehensive view of disease dynamics and mechanisms, positioning it as a pioneer in autoimmune precision medicine.
Promise Bio
PromiseBio is a precision medicine company specializing in autoimmune diseases through epiproteomic analysis. It uses a cloud-based AI platform to perform broad-range, unbiased analyses of standard mass-spectrometry data, revealing biologically relevant insights into protein post-translational modifications that regulate disease mechanisms. The company leverages explainable AI and clinically-oriented algorithms to provide scalable, accurate predictions for treatment selection, early response assessment, disease monitoring, biomarker discovery, patient selection, and clinical trial enrichment. PromiseBio's approach enables revisiting existing data with evolving AI models without chemical enrichment, offering a comprehensive view of disease dynamics and mechanisms, positioning it as a pioneer in autoimmune precision medicine.